SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Good Cancer research Bio company?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (49)10/11/1996 3:10:00 PM
From: scaram(o)uche   of 76
 
Thanks, Henry. I think that everyone expects big things from Idun, given the merger and the big names. I don't think much of LXR, and the exit of their scientist-founder (Phil Barr) is a red flag.

Here's a nifty twist on apoptosis and cancer. When we think of apop, we think of LGND-like stuff, where tumor cells are induced to commit suicide. However, Ariad (ARIA) is working on making passively transfered cytotoxic effector cells go *poof* on command. Clever? We'll see.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News